The Genetic Revolution: Pharma Giants Target Lipoprotein(a) to Combat Heart Disease
, , ,

The Genetic Revolution: Pharma Giants Target Lipoprotein(a) to Combat Heart Disease

A high-stakes pharmaceutical race is underway as industry leaders Novartis, Amgen, and Eli Lilly compete to develop breakthrough treatments for lipoprotein(a), or Lp(a), a form of cholesterol governed primarily by genetics. While conventional LDL cholesterol can often be mitigated through lifestyle modifications, Lp(a) levels are biologically fixed. This genetic predisposition leaves millions of people at […]
Sun Pharmaceutical Executes $11.75 Billion Acquisition of Organon to Boost Global Market Presence
, , ,

Sun Pharmaceutical Executes $11.75 Billion Acquisition of Organon to Boost Global Market Presence

Sun Pharmaceutical Industries has reached a definitive agreement to acquire Organon & Co in an all-cash deal valued at $11.75 billion, inclusive of debt. This strategic move is set to significantly bolster the Indian pharmaceutical company’s standing in the global market, pushing its annual revenue to approximately $12.4 billion and securing its place among the […]
Eli Lilly Bolsters Oncology Portfolio with $2.3 Billion Acquisition of Ajax Therapeutics
, , ,

Eli Lilly Bolsters Oncology Portfolio with $2.3 Billion Acquisition of Ajax Therapeutics

Eli Lilly has officially entered into a definitive agreement to acquire Ajax Therapeutics, a private biotechnology firm, in a transaction valued at up to $2.3 billion. The strategic move is designed to significantly enhance the pharmaceutical giant’s oncology pipeline, specifically focusing on the treatment of myelofibrosis, a rare and debilitating chronic blood cancer that impairs […]